Erectile Dysfunction Is Associated with a High Prevalence of Hyperlipidemia and Coronary Heart Disease Risk von Roumeguère, Th, Wespes, E, Carpentier, Y, Hoffmann, P, Schulman, C.C

Volltext

Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses von Noel, J.C., Thiry, L., Verhest, A., Deschepper, N., Peny, M.O., Sattar, A.A., Schulman, C.C., Haot, J.

Volltext

Editorial Note von Schulman, C.C.

Volltext

Editorial Note von Schulman, C.C.

Volltext

Handling and Reporting of Biopsy and Surgical Specimens of Testicular Cancer von Winstanley, A.M, Mikuz, G, Debruyne, F, Schulman, C.C, Parkinson, M.C

Volltext

Nutrition and prostate cancer: evidence or suspicion? von Schulman, C.C, Ekane, S, Zlotta, A.R

Volltext

What Is the Optimal Regimen for BCG Intravesical Therapy? von Zlotta, A.R., van Vooren, J.P., Huygen, K., Drowart, A., Decock, M., Pirson, M., Jurion, F., Palfliet, K., Denis, O., Simon, J., Schulman, C.C.

Volltext

Is One Set of Sextant Biopsies Enough to Rule Out Prostate Cancer? Influence of Transition and Total Prostate Volumes on Prostate Cancer Yield von Djavan, B., Zlotta, A.R., Ekane, S., Remzi, M., Kramer, G., Roumeguère, T., Etemad, M., Wolfram, R., Schulman, C.C., Marberger, M.

Volltext

Turapy-Transurethral Ablation Prostatectomy by High Temperature Radiofrequency-Preliminary Results of A Multicenter Study von SCHULMAN, C.C.

Volltext

PD-01.02 von Scattoni, V., Ben Addi, T., Schulman, C.C., Rigatti, P., Montorsi, F., Zlotta, A.R.

Volltext

PD-01.01 von Scattoni, V., Ben Addi, T., Hoffman, P., Schulman, C.C., Rigatti, P., Montorsi, F., Zlotta, A.R.

Volltext

PD-02.07 von Zlotta, A.R., Ben Addi, T., Schulman, C.C., Rigatti, P., Scattoni, V., Montorsi, F.

Volltext

Tamsulosin: 3-Year Long-Term Efficacy and Safety in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Analysis of a European, Multinational, Mu... von Schulman, C.C., Cortvriend, J., Jonas, U., Lock, T.M.T.W., Vaage, S., Speakman, M.J.

Volltext

PD-02.07: Serum prostate-specific antigen is a predictor of the transition zone volume rather than total prostate volume in men with benign prostatic hyperplasia von Zlotta, A.R., Ben Addi, T., Schulman, C.C., Rigatti, P., Scattoni, V., Montorsi, F.

Volltext

PD-01.02: The PSA era is not over for detecting prostate cancer: correlations between PSA levels and transition zone volume in 1952 men with PSA levels < 10 ng / ml who underwent 1... von Scattoni, V., Ben Addi, T., Schulman, C.C., Rigatti, P., Montorsi, F., Zlotta, A.R.

Volltext

PD-01.01: Even in low PSA ranges (0-2.5 ng/ml/cc) the PSA density of the transition zone is a very significant adjunct to serum PSA in differentiating prostate cancer from benign d... von Scattoni, V., Ben Addi, T., Hoffman, P., Schulman, C.C., Rigatti, P., Montorsi, F., Zlotta, A.R.

Volltext

Extraperitoneal Laparoscopic Radical Prostatectomy von Bollens, R., Vanden Bossche, M., Roumeguere, Th, Damoun, A., Ekane, S., Hoffmann, P., Zlotta, A.R., Schulman, C.C.

Volltext

Early Prostate Cancer: Prevention, Treatment Modalities, and Quality of Life Issues von Moul, J.W, Anderson, J, Penson, D.F, Klotz, L.H, Soloway, M.S, Schulman, C.C

Volltext

933 MRI AND PROSTATE CANCER: THE INFLUENCE OF PROSTATE WEIGHT ON TUMOUR LOCALIZATION von Goris, M.C, Peltier, A, Lemort, M, Bollens, R, Roumeguere, T, Schulman, C.C, Van, Velthoven R

Volltext

647 WHAT IS THE LONG TERM PROGNOSTIC VALUE OF PROAPOPTOTIC, ANTI-APOPTOTIC, PROLIFERATION AND INVASIVENESS MOLECULAR MARKERS IN PATIENTS TREATED WITH BCG FOR HIGH RISK NON-INVASIVE... von Alkhateeb, S.S, Neill, M.G, Van Rhijn, B.W, Kakiashvili, D, Fleshner, N.E, Jewett, M.A.S, Bar-Moshe, S, Petein, M, Schulman, C.C, Roumeguere, T, Rorive, S, Zlotta, A.R

Volltext